0.05Open0.05Pre Close0 Volume2 Open Interest7.50Strike Price0.00Turnover778.02%IV2433.56%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.2835Delta0.5589Gamma5.97Leverage Ratio-0.0041Theta0.0000Rho1.69Eff Leverage0.0003Vega
Renalytix Stock Discussion
Renalytix plc, a leading artificial intelligence-enabled in vitro diagnostics company, has announced an exciting new collaboration with the Steno Diabetes Center in Copenhagen. This partnership aims to advance precision medicine solutions for patients suffering from diabetes and chronic kidney disease ...
?????????????????????
No comment yet